Hc Advisors, LLC Reata Pharmaceuticals Inc Transaction History

Hc Advisors, LLC

  • $117 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021
SELL
$94.25 - $132.81 $702,162 - $989,434
-7,450 Closed
0 $0
Q4 2020

Feb 08, 2021
SELL
$102.03 - $184.62 $12,651 - $22,892
-124 Reduced 1.64%
7,450 $921,000
Q3 2020

Nov 04, 2020
SELL
$93.53 - $163.34 $47,139 - $82,323
-504 Reduced 6.24%
7,574 $738,000
Q2 2020

Aug 12, 2020
BUY
$126.3 - $176.56 $1.02 Million - $1.43 Million
8,078 New
8,078 $1.26 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Hc Advisors, LLC Portfolio

Follow Hc Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hc Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email